Amiloxate
From Wikipedia, the free encyclopedia
| Names | |
|---|---|
| IUPAC name
3-Methylbutyl (2E)-3-(4-methoxyphenyl)acrylate
|
|
| Other names
Isopentyl 4-methoxycinnamate; Isoamyl p-methoxycinnamate
|
|
| Identifiers | |
| 71617-10-2 | |
| ChEMBL | ChEMBL1476782 |
| ChemSpider | 1266578 |
|
|
| Jmol-3D images | Image |
| PubChem | 1549789 |
|
|
| Properties | |
| C15H20O3 | |
| Molar mass | 248.32 g·mol−1 |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
| Infobox references | |
Amiloxate is a sunscreening agent. It is approved for use in the European Union and is undergoing regulatory evaluation in the United States.[1][2]
See also[edit]
References[edit]
- ^ Brian Palmer. "Burned by Bureaucracy: Why is the FDA stalling on newer and better sunscreens?". Slate.com.
- ^ Britt Erickson (May 12, 2014). "Sunscreen Delays". Chemical & Engineering News 92 (19): 27.
|
||||||||||||||||||||||
| This article about an ester is a stub. You can help Wikipedia by expanding it. |